Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 76,247 | 88,205 | 139,259 | 203,126 | 127,436 |
| Marketable Securities | 817,463 | 688,723 | 643,860 | 816,892 | 445,493 |
| Receivables | 4,109 | 2,810 | 2,206 | 4,378 | N/A |
| Inventories | 27,616 | 19,076 | 8,492 | 0 | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 47,859 |
| TOTAL | $965,600 | $833,835 | $832,772 | $1,064,231 | $636,677 |
| Non-Current Assets | |||||
| PPE Net | 11,675 | 15,382 | 22,987 | 28,923 | 30,815 |
| Investments And Advances | 638,321 | 29,435 | 313,874 | 266,375 | 97,608 |
| Other Non-Current Assets | 47,603 | 58,466 | 69,085 | 78,207 | 87,852 |
| TOTAL | $697,599 | $103,283 | $405,946 | $373,505 | $216,275 |
| Total Assets | $1,663,199 | $937,118 | $1,238,718 | $1,437,736 | $852,952 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,643 | 9,780 | 18,616 | 16,700 | 17,724 |
| Accrued Expenses | 46,861 | 43,167 | 30,350 | 31,967 | 30,801 |
| TOTAL | $81,156 | $67,955 | $62,629 | $59,826 | $94,394 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 41,087 | 58,144 | 75,275 | 85,659 | 358,727 |
| TOTAL | $41,087 | $58,144 | $75,275 | $85,935 | $359,058 |
| Total Liabilities | $122,243 | $126,099 | $137,904 | $145,761 | $453,452 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,296 | 56,195 | 55,285 | 54,638 | 69,601 |
| Common Shares | 73 | 72 | 71 | 71 | 69 |
| Retained earnings | -148,924 | -822,649 | -470,561 | -238,760 | -1,843,475 |
| Other shareholders' equity | -2,004 | -927 | -13,021 | -1,684 | 105 |
| TOTAL | $1,540,956 | $811,019 | $1,100,814 | $1,291,975 | $399,500 |
| Total Liabilities And Equity | $1,663,199 | $937,118 | $1,238,718 | $1,437,736 | $852,952 |